136 related articles for article (PubMed ID: 36309864)
1. A Multidisciplinary Thyroid Eye Clinic: A One-stop Shop.
Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Winter H; Huna-Baron R; Wygnanski-Jaffe T; Ben Simon G
Isr Med Assoc J; 2022 Oct; 24(10):671-676. PubMed ID: 36309864
[TBL] [Abstract][Full Text] [Related]
2. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel.
Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):2009-2015. PubMed ID: 33528651
[TBL] [Abstract][Full Text] [Related]
3. Management of patients in a combined thyroid eye clinic in secondary care.
Benzimra JD; Quinn AG; Kersey T; McGrane D; Goss L; Vaidya B
Int Ophthalmol; 2014 Feb; 34(1):1-6. PubMed ID: 23549634
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in clinical presentation and prognosis of thyroid eye disease.
Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
Eur J Ophthalmol; 2021 Sep; 31(5):2717-2723. PubMed ID: 33158379
[TBL] [Abstract][Full Text] [Related]
5. Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States.
Wang Y; Sharma A; Padnick-Silver L; Francis-Sedlak M; Holt RJ; Foley C; Massry G; Douglas RS
Ophthalmol Ther; 2021 Mar; 10(1):75-87. PubMed ID: 33196932
[TBL] [Abstract][Full Text] [Related]
6. Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States.
Cockerham KP; Padnick-Silver L; Stuertz N; Francis-Sedlak M; Holt RJ
Ophthalmol Ther; 2021 Dec; 10(4):975-987. PubMed ID: 34478126
[TBL] [Abstract][Full Text] [Related]
7. Thyroid eye disease presenting with superior rectus/levator complex enlargement.
Wang Y; Mettu P; Broadbent T; Radke P; Firl K; Shepherd JB; Couch SM; Nguyen A; Henderson AD; McCulley T; McClelland CM; Mokhtarzadeh A; Lee MS; Garrity JA; Harrison AR
Orbit; 2020 Feb; 39(1):5-12. PubMed ID: 31056988
[No Abstract] [Full Text] [Related]
8. Evaluation of thyroid eye disease: quality-of-life questionnaire (TED-QOL) in Korean patients.
Son BJ; Lee SY; Yoon JS
Can J Ophthalmol; 2014 Apr; 49(2):167-73. PubMed ID: 24767223
[TBL] [Abstract][Full Text] [Related]
9. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal association of thyroid-stimulating immunoglobulin levels with clinical characteristics in thyroid eye disease.
Ko J; Kook KH; Yoon JS; Woo KI; Yang JW;
BMJ Open; 2022 Jun; 12(6):e050337. PubMed ID: 35728893
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of thyroid-stimulating immunoglobulin as a biomarker of the activity of thyroid eye disease.
Jeon H; Lee JY; Kim YJ; Lee MJ
Eye (Lond); 2023 Feb; 37(3):543-547. PubMed ID: 35220401
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory and Noninflammatory Thyroid Eye Disease: Comparison of Disease Signs, Symptoms, and Quality of Life in Patients in the United States.
Wang Y; Padnick-Silver L; Francis-Sedlak M; Holt RJ; Foley C; Douglas RS
Endocr Pract; 2022 Sep; 28(9):842-846. PubMed ID: 35714862
[TBL] [Abstract][Full Text] [Related]
13. Bilateral versus unilateral thyroid eye disease.
Kashkouli MB; Kaghazkanani R; Heidari I; Ketabi N; Jam S; Azarnia S; Pakdel F
Indian J Ophthalmol; 2011; 59(5):363-6. PubMed ID: 21836341
[TBL] [Abstract][Full Text] [Related]
14. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
[TBL] [Abstract][Full Text] [Related]
15. The epidemiological characteristics of patients with thyroid eye disease in a referral center in northern Iran.
Medghalchi A; Akbari M; Alizadeh Y; Moghadam RS
J Curr Ophthalmol; 2018 Dec; 30(4):353-358. PubMed ID: 30555970
[TBL] [Abstract][Full Text] [Related]
16. A Chinese survey of clinical practice on the management of thyroid eye disease.
Chen J; Li C; Teng W; Shan Z; Jin J; Wei Y; Sun J; Li Y; Zhou H
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642583
[TBL] [Abstract][Full Text] [Related]
17. The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey.
Estcourt S; Hickey J; Perros P; Dayan C; Vaidya B
Eur J Endocrinol; 2009 Sep; 161(3):483-7. PubMed ID: 19542244
[TBL] [Abstract][Full Text] [Related]
18. Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration.
Quinn AS; Dujardin LR; Knight B; Benzimra J; Quinn AG; Vaidya B
Int Ophthalmol; 2018 Feb; 38(1):301-306. PubMed ID: 28181061
[TBL] [Abstract][Full Text] [Related]
19. Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease.
Fayers T; Dolman PJ
Br J Ophthalmol; 2011 Dec; 95(12):1670-4. PubMed ID: 21951566
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
